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We used a lentiviral system for expressing secreted human Aβ in the brains of young and
old APOE knock-in mice. This system allowed us to examine Aβ metabolism in vivo, and
test the effects of both aging and APOE genotype, two of the strongest risk factors for
Alzheimer’s disease. We injected the Aβ1−42 lentivirus into the motor cortex of young
(2 month old) and old (20–22 month old) APOE3 and APOE4 mice. After 2 weeks of
lentiviral expression, we analyzed the pattern of Aβ accumulation, glial activation, and
phosphor-tau. In young mice, Aβ accumulated mainly within neurons with no evidence of
extracellular Aβ. Signiﬁcantly higher levels of intraneuronal Aβ were observed in APOE4
mice compared to APOE3 mice. In old mice, APOE4 predisposed again to higher levels
of Aβ accumulation, but the Aβ was mainly in extracellular spaces. In younger mice, we
also observed Aβ in microglia but not astrocytes. The numbers of microglia containing Aβ
were signiﬁcantly higher in APOE3 mice compared to APOE4 mice, and were signiﬁcantly
lower in both genetic backgrounds with aging. The astrocytes in old mice were activated
to a greater extent in the brain regions where Aβ was introduced, an effect that was again
increased by the presence of APOE4. Finally, phospho-tau accumulated in the region of
Aβ expression, with evidence of extracellular phospho-tau increasing with aging. These
data suggest that APOE4 predisposes to less microglial clearance of Aβ, leading to more
intraneuronal accumulation. In older brains, decreased clearance leads tomore extracellular
Aβ, and more downstream consequences relating to astrocyte activation and phospho-tau
accumulation. We conclude that both aging and APOE genotype affect pathways related
to Aβ metabolism by microglia.
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INTRODUCTION
Aging is the most notable risk factor for AD: the incidence of AD
increases exponentially with aging, particularly affecting the pop-
ulation after age 60 (Reitz and Mayeux, 2014). Pathologically, the
AD brain is characterized by the accumulation of the Aβ peptide
in amyloid plaques, the accumulation of phosphorylated tau in
neuroﬁbrillary tangles, and the loss of synapses (Spires-Jones and
Hyman, 2014). Genetically, AD is most strongly affected by the
APOE gene: inheritance of the common APOE-ε4 allele increases
risk of AD three fold, and over 10-fold in individuals with two
APOE-ε4 alleles (Lambert et al., 2013). Whether APOE and aging
affect pathogenesis of AD via similar or distinct pathways is not
known.
Animalmodels of ADhave beenused to investigate the effects of
APOEonADpathogenesis. TransgenicADmousemodels express-
ing the different APOE isoforms showed earlier accumulation of
amyloid in the presence of APOE-ε4 (Kim et al., 2009), consis-
tent with higher levels of amyloid seen in humans with APOE-ε4
(Rebeck et al., 1993; Schmechel et al., 1993; Reiman et al., 2009).
Abbreviations: AD, Alzheimer’s disease; Aβ, Amyloid β; apoE, Apolipoprotein E;
DAB, 3,3-diaminobenzidine; PBS, phosphate-buffered saline.
These studies have led to the hypothesis that APOE genotype
affects clearance of Aβ, into glia or into the periphery (Castellano
et al., 2011). Cell culture experiments also show that apoE3 pro-
motes cellular uptake of Aβ in microglia (Mandrekar et al., 2009;
Lee et al., 2012). These kinds of approaches have supported a role
of APOE in altering Aβ clearance.
It is difﬁcult to examine the effects of aging on Aβ accumu-
lation in these models of Aβ metabolism, because the animals
generally express very high levels of Aβ from birth (Ashe and
Zahs, 2010). We have been using a lentiviral construct for express-
ing Aβ at speciﬁc times and in different genetic backgrounds
(Burns et al., 2009; Khandelwal et al., 2011; Lonskaya et al., 2013).
This construct expresses Aβ containing a signal peptide, lead-
ing to secretion of Aβ from infected neurons (Rebeck et al.,
2010). Using this construct, we found that infection of 9 month
old APOE4 knock-in mice led to higher levels of intraneu-
ronal Aβ compared to APOE3 mice (Zhao et al., 2014). Inter-
estingly, APOE3 mice showed a greater number of microglia
containing the introduced Aβ compared to the APOE4 mice
(Zhao et al., 2014). Neither wild-type mice nor either APOE
mouse model showed evidence of extracellular Aβ accumula-
tion (Rebeck et al., 2010; Zhao et al., 2014). We hypothesized
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that apoE3 promoted clearance of Aβ by microglia, while apoE4
favored less glial clearance and more intraneuronal accumula-
tion.
We now used this system to examine the effects of aging
on Aβ metabolism. We infected young (2 month old) and old
(20–22 month old) mice of APOE3 or APOE4 genotypes with
this lentiviral Aβ construct, and measured pathogenic effects.
The aged mice showed extracellular accumulation of Aβ, and
greater downstream effects on astrocyte activation and phospho-
tau levels. These differences were generally exacerbated by the
presence of APOE4. We conclude that APOE4 and aging both




Female APOE3 and APOE4 mice at the age of 2 months (young)
and 20–22 months (old) were used in the present study. APOE
knock-in mice, created by gene targeting, were the gift of Patrick
Sullivan (Sullivan et al., 1997). These mice express each of the
human APOE isoforms under the control of endogenous murine
APOE regulatory sequences. All animalswere bred andmaintained
in a temperature and humidity controlled vivariumatGeorgetown
University Medical Center, with ad libitum access to food and
water on a 12 h light dark cycle. All experiments were approved
and conducted according to Georgetown University Animal Care
and Use Committee. Every effort was made to minimize suffering
and the number of animals used for this study.
LENTIVIRAL GENERATION
A gene transfer animal model was generated by using lentiviral
delivery Aβ1−42 expression to speciﬁc brain regions that results
in intracellular protein accumulation (Rebeck et al., 2010; Zhao
et al., 2014). The lentivirus expresses Aβ1−42 with a signal pep-
tide cloned into a pLenti6-D-TOPO plasmid under the control of
the cytomegalovirus promoter (Burns et al., 2009). Lentivirus was
generated inHEK293FT cells, and the supernatants were collected,
concentrated by centrifugation, resuspended in Hank’s Balanced
Salt Solution, and aliquoted in autoclaved tubes. To assure that the
same number and quality of viral particles were injected, we used
the same preparation of virus and injected it into the young and
old APOE3 and APOE4 mice over a period of 2 days.
STEREOTAXIC INJECTION
As in previous studies, we performed stereotaxic injection of
Aβ1−42 lentivirus to primarymotor cortex, which generated intra-
neuronal expression of Aβ1−42 in brain cortex (Burns et al., 2009;
Rebeck et al., 2010; Herman et al., 2011; Algarzae et al., 2012;
Lonskaya et al., 2013; Zhao et al., 2014). Motor cortex was cho-
sen because of the reliability of the injection site, and because, in
AD brains, Aβ deposits typically occur ﬁrst in neocortical areas
(Braak and Braak, 1991; Thal et al., 2002; Jack et al., 2009, 2010).
Our earlier studies with this lentiviral Aβ construct using a control
lentiviral LacZ construct demonstrated that 2weeks after injection,
control injections showed no evidence of Aβ deposition, glial acti-
vation of phospho-tau induction (Burns et al., 2009; Rebeck et al.,
2010; Herman et al., 2011).
Animals were anesthetized with intraperitoneal injection of a
cocktail of ketamine and xylazine (100 and 10mg/kg, respectively).
Stereotaxic surgery was then performed to inject the lentivirus
encoding Aβ1−42 into the left side of the primary motor cortex of
young and oldAPOE3 orAPOE4mice, as described (Hebron et al.,
2013). The stereotaxic coordinates for the primary motor cortex
of mice were 1.6 mm lateral (left), 1.6 mm ventral and 0.5 mm
anterior. Viral stocks were injected through a microsyringe pump
controller (Micro4) using total pump (World Precision Instru-
ments, Inc.) delivery of 6 μl at a rate of 0.2 μl/min. The needle
remained in place at the injection site for an additional minute
before slow removal over 2 min.
FIXATION AND TISSUE PROCESSING
2 weeks post-injection, the mice were deeply anesthetized by
intraperitoneal injection of ketamine-xylazine and then ﬁxed
by transcardial perfusion with PBS; pH 7.4), followed by 4%
paraformaldehyde. Brains were removed and post-ﬁxed in 4%
paraformaldehyde at 4◦C overnight, incubated in two sequential
30% sucrose solutions at 4◦C for 24 h each, frozen on dry ice, and
coronal sections of the brain were cut (30 μm thick) on a sliding
microtome (Thermo Scientiﬁc Microm HM 430). Sections were
stored in cryoprotectant (30% glycerin, 30% ethylene glycol, in
0.1 M PBS) at −20◦C. A total of n = 24 mice (n = 6 mice for each
group) were used for immunohistochemistry.
ANTIBODY AND REAGENTS
Monoclonal antibody MOAB2 and biotinylated MOAB2 (mouse
IgG2b, 0.5 mg/ml) were used for the determination of lentiviral
Aβ1−42 in immunoﬂuorescence and DAB staining, respectively,
(Youmans et al., 2012). Rabbit anti-NeuN antibody (Bioss, Inc.),
rabbit anti-GFAP antibody (Invitrogen, CA, USA) and rabbit
anti-Iba1 antibody (Wako Pure Chemical Industries) were used
for the identiﬁcation of neurons, astrocytes and microglial cells,
respectively. Phosphorylated tau was detected by a rabbit anti-tau
[pSpS199/202] phospho-speciﬁc antibody AT8 (Invitrogen, CA,
USA). Biotinylated goat anti-rabbit secondary antibodies (Vectas-
tain, Vector Laboratories) were used for DAB immunostaining of
GFAP and phosphorylated tau. Fluorescent secondary antibodies:
Alexa Fluor 594 donkey anti-mouse and Alexa Fluor 488 donkey
anti-rabbit were from Invitrogen (CA, USA). The antibodies were
diluted in PBS containing 0.25%Triton X-100+ 2% bovine serum
albumin + 0.005% sodium azide.
DAB IMMUNOSTAINING
For DAB immunohistochemistry, 30 μm coronal brain sections
from young and old APOE3 and APOE4 mice were rinsed in
0.1 M PBS (6 × 10 min), incubated in quench peroxidase (10%
methanol, 3% hydrogen peroxide in 1 × PBS) for 20 min and
permeabilized with PBS containing 0.25% Triton X-100. After-
ward, sections were incubated with 10% normal horse serum for
1 h at room temperature to block nonspeciﬁc surfaces. Sections
were then incubated with biotinylated MOAB2 (mouse, 1:1000
dilution of 0.5 mg/ml stock), speciﬁc primary antibody to GFAP
(rabbit, 1:1000) or phosphorylated tau (rabbit, 1:10 000) at
4◦C overnight. After incubation, samples were washed in PBS
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(3 × 10 min), incubated with biotinylated goat anti-rabbit sec-
ondary antibody (1:200) for GFAP and phosphorylated tau for
1 h. Sections were then washed with PBS (3 × 10 min), incu-
bated with avidin–biotin complex (Vector Laboratories) for 1 h,
washed in PBS (2 × 15 min) and rinsed in 0.1 M Tris–HCl (pH
7.5) for 3 min. After that, reaction products were visualized using
0.1 M Tris-HCl (pH 7.5) containing 0.05% DABtetrahydrochlo-
ride and 0.003% hydrogen peroxide. Sections were then washed in
0.1 M Tris-HCl (pH 7.5) buffer (3 × 5 min), mounted onto glass
slides, air dried overnight, dehydrated through a series of graded
alcohols, cleared in xylene and cover-slipped with permount.
Bright-ﬁeld images were taken on a Zeiss Axiophot microscope
(Carl Zeiss).
NISSL STAINING
Tissue sections were counter-stained with a Nissl stain (cresyl
violet) after DAB immunostaining to recognize cellular details.
Coverslips were gently removed with xylene, brain sections were
rehydrated with decreasing ethanol concentrations (100, 100, 95,
70%) for 5 min each, washed with distilled water for 5 min and
treated with 0.1% cresyl violet acetate solution for 5 min at room
temperature. The sections were then dehydrated with ascending
series of ethanol (70, 95, 100, 100%), treated with xylene and
cover-slipped with permount. Bright-ﬁeld images were taken with
an Olympus BX51 microscope and DP-72 CCD camera.
IMMUNOFLUORESCENCE AND CONFOCAL MICROSCOPY
A series of double label immunoﬂuorescence experiments were
conducted to determine the colocalization characteristics of
lentiviral Aβ1−42 with speciﬁc cell-type antibodies. Brain sections
were incubated in themixture of two primary antibodies: MOAB2
(mouse, 1:1000) and either NeuN (rabbit, 1:1000), GFAP (rabbit,
1:1000), or Iba1 (rabbit, 1:100), overnight 4◦C. Sections were then
washed in PBS (6 × 10 min) and incubated with the mixture of
two ﬂuorophore-conjugated secondary antibodies of Alexa Fluor
594 donkey anti-mouse, andAlexa Fluor 488 donkey anti-rabbit at
dilution of 1:1000 for 1 h at room temperature in the dark. Images
were captured on a Zeiss LSM 510 confocal microscope.
ANALYSIS OF IMMUNOSTAINING
The region for quantitative analysis was in the ipsilateral cortex
nearest to the injection site of Aβ1−42 lentivirus, which contains
most MOAB2-positive neurons. Analysis of Aβ by DAB staining
occurred in two sections fromeach animal nearest the injection site
(sections were subsequently counterstained for Nissl). The three
immunoﬂuorescent doubles stains of Aβ with individual cell-type
markers were conducted in single sections from each animal, but
using sections near the injection site because the Aβ assay was
more sensitive. DAB immunostains for astrocytes (more proximal
to the injection site) and the phospho-tau epitope (more distal to
the injection site) were conducted on sections from a subset of at
least three brains.
Images were captured at 40× magniﬁcation using a Zeiss LSM
510 confocal microscope across an area of 675 μm × 675 μm. As
in our previous study (Zhao et al., 2014), we performed manual
quantiﬁcation of MOAB2-positive cells, Iba1-positive cells, and
MOAB2/Iba1-double-positive cells, following a modiﬁed proce-
dure (Cerbai et al., 2012).We took the following steps to guarantee
accurate counts: (1) The region we chose for quantitative analysis
was in the ipsilateral cortex nearest to the injection site of Aβ1−42
lentivirus, which containsmostMOAB2-positive neurons. (2) The
pictures of nine 40× microscopic ﬁelds (675 μm × 675 μm)
were taken automatically by a two-dimension scanning mecha-
nism microscope stage. (3) The numbers of MOAB2- positive,
Iba1-positive and MOAB2-/Iba1-double-positive cells were man-
ually counted by a blinded investigator. (4) The cell numbers
were determined in three sections per animal, and the average
of the counts thus obtained was recorded from young APOE3, old
APOE3, young APOE4, and old APOE4 groups (n = 6 mice in
each group).
STATISTICAL ANALYSIS
Fisher’s exact test was performed to test the frequency difference
of MOAB2 immunostaining (positive versus negative) between
groups of young APOE3, old APOE3, young APOE4, and old
APOE4 mice. Two-way ANOVA was used to examine differ-
ences in numbers of MOAB2-, Iba1-, and MOAB2-/Iba1-double
immunopositive cells among groups, followed by Tukey’s post hoc
analyses. Data were expressed as mean ± SEM unless otherwise
speciﬁed. The statistical signiﬁcance criterion of P-value was 0.05.
RESULTS
Aβ IN GLIA IN YOUNG MICE AND ITS EXTRACELLULAR ACCUMULATION
IN AGED MICE
Intraneuronal accumulation of Aβ is a potentially important fac-
tor participating in AD pathogenesis (LaFerla et al., 2007; Bayer
and Wirths, 2010; Wirths and Bayer, 2012). Our previous work
demonstrated that intracellular accumulation of human Aβ1−42
was enhanced in the cerebral cortexof eight to 9-montholdAPOE4
mice when compared to APOE3 mice 2 weeks after injection of
an Aβ1−42 lentivirus (Zhao et al., 2014). In the current study,
Aβ1−42 lentivirus was injected into the primary motor cortex of
young (2 month old) APOE3 and APOE4 mice, as well as old
(20–22 month old) APOE3 and APOE4 mice. Aβ was measured
2 weeks after the injection.
Immunohistological stainingwithMOAB2, a pan-speciﬁc anti-
body to Aβ42 (Youmans et al., 2012) showed that the level of
Aβ was strong in the ipsilateral cortex near the injection area
and absent in the contralateral cortex (Figure 1A). Seven of 24
(29%) sections from young APOE3 mice, 16 of 24 (67%) from
young APOE4 mice, 5 of 24 (21%) from old APOE3 mice, and
14 of 24 (58%) from old APOE4 mice were positively stained
for MOAB2. Consistent with our previous results from APOE3
and APOE4 mice (Zhao et al., 2014), we found there were sig-
niﬁcantly more MOAB2-positive sections in APOE4 mice than
in APOE3 mice, in both the young and old cohorts (Figure 1B,
∗P < 0.05, old APOE4 versus old APOE3; ∗∗P < 0.01, young
APOE4 versus young APOE3; Fisher’s exact test). There were no
signiﬁcant differences between young and old groups (Figure 1B).
Sections stained with DAB for Aβ (brown) were also counter-
stained with Nissl (blue; Figure 1C). In addition to punctate
accumulation in neuron-like cells (arrows), Aβ was also strongly
present in glia-like cells (solid arrowheads) in young APOE3 and
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FIGURE 1 | Age and APOE genotype affect accumulation of Aβ1−42
after lentivirus injection. (A) Representative images of DAB staining
(brown) for biotinylated anti-Aβ antibody, MOAB2 on the contralateral
and ipsilateral (left) brain cortex near the injection area from young
(2 month old) APOE3, young APOE4, old (20–22 months old) APOE3,
and old APOE4 mice. Scale bars: 50 μm. (B) The percentage of
MOAB2-positive sections was signiﬁcantly higher in APOE4 mice than
that in APOE3 mice (**P < 0.01, young APOE4 versus young APOE3;
*P < 0.01, old APOE4 versus old APOE3, Fisher’s exact test).
(C) Combination of DAB-labeling immunocytochemistry for MOAB2
(brown) with Nissl staining (blue) in the contralateral and ipsilateral
cortex near the injection site of Aβ1−42 lentivirus on the brain
sections. Scale bars: 50 μm. Arrows and indicate intracellular MOAB-2
immunopositive staining in neuron-like cells; solid arrowheads indicate
intracellular MOAB-2 immunopositive staining in glia-like cells in the
ipsilateral cortex of young APOE3- and APOE4 mice; hollow
arrowheads indicate extracellular MOAB-2 immunopositive staining in
the ipsilateral cortex of old APOE3- and APOE4 mice.
APOE4 mice. Conversely, in old APOE3 and APOE4 mice, Aβ was
observed extracellularly (hollow arrowheads), with less evidence
of glial Aβ (Figure 1C). These deposits were more of the size and
shape of individual cells and did not appear like spherical amyloid
plaques.
AGE-RELATED CHANGES OF INTRACELLULAR Aβ ACCUMULATION IN
NEURONS AND MICROGLIA
3,3-diaminobenzidine immunostaining only shows the areas with
high levels of Aβ, so we moved to immunoﬂuorescence to demon-
strate more of the Aβ in the tissue. Using immunohistochemical
markers, we examined which cells accumulated Aβ in both
the young and the old mouse brains. Double immunostaining
for Aβ1−42 (MOAB2, red) and markers of different cell-types
(NeuN/ Iba1/ GFAP, green) showed intracellular accumulation
of Aβ in ipsilateral cortical neurons (NeuN, Figure 2A) and
in microglia (Iba1, Figure 2C) near the injection site, but
not in astrocytes (GFAP, Figure 2B) of all mice. Although
the immunopositive staining for Aβ1−42 (MOAB2, red) was
mostly found in neurons of both young and old mice with
a perinuclear localization (Figure 2A), a small amount was
also present in glia-like cells in young mice (solid arrowheads).
This glial accumulation of Aβ was further evidenced by dou-
ble immunostaining of MOAB2 and Iba1 (Figure 2C). In the
young APOE3 and APOE4 mice, the Aβ was widespread through-
out the somata and branched processes of the microglia (solid
arrowheads, Figure 2C). Conversely, in aged mice, Aβ localized
mainly in the microglia somata but not in the processes (hollow
arrowheads, Figure 2C). Importantly, Aβ was also localized extra-
cellularly in old APOE3 and old APOE4mice (arrows, Figure 2A),
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FIGURE 2 | Age and APOE genotype affect Aβ1−42 accumulation in
neurons and glia. (A) Aβ1−42 (MOAB2, red) is mainly present in cortical
neurons (NeuN, green) of all mice 2 weeks after injection of lentivirus.
Solid arrowheads indicate intracellular MOAB-2 immunopositive staining in
glia-like cells in the ipsilateral cortex of young APOE3 and APOE4 mice;
arrow indicate extracellular MOAB-2 immunopositive staining in the
ipsilateral cortex of APOE3 and APOE4 mice. Scale bar: 10 μm.
(B) Aβ1−42 (MOAB2, red) was not observed in astrocytes (GFAP, green)
of any mice. Scale bar: 10 μm. (C) Aβ1−42 (MOAB2, red) was present in
some microglia (Iba1, green) of all mice. Solid arrowheads indicate
intracellular MOAB-2 immunopositive staining widespread throughout the
somata and branched processes of microglia in the ipsilateral cortex of
young APOE3 and APOE4 mice; hollow arrowheads indicate MOAB-2
immunopositive staining mainly in the microglia somata in the ipsilateral
cortex of old APOE3 and APOE4 mice. Scale bar: 10 μm. (D) The average
numbers of MOAB2-positive neurons per mouse in the ipsilateral cortex
near the injection site of Aβ1−42 lentivirus. There were signiﬁcantly more
MOAB-2 positive neurons in APOE4 brains compared to APOE3 brains,
and in older brains compared to younger brains. (E) N o signiﬁcant
differences were observed for the numbers of microglia in the ipsilateral
cortex near the lentiviral injection site, as determined from Iba1 stains.
(F) MOAB2-positive microglia (MOAB2-/Iba1-double-positive cells) per
mouse in the ipsilateral cortex near the injection site. Data are expressed
as mean + SEM and were analyzed by two-way ANOVAs followed by
Tukey’s post hoc analyses. **P < 0.01, young APOE3 versus old APOE3;
*P < 0.05, young APOE3 versus old APOE3; ##P < 0.01, young APOE4
versus old APOE4; ++P < 0.01, old APOE3 versus old APOE4;
+P < 0.05, old APOE3 versus old APOE4.
indicating the extracellular accumulation of Aβ only in aged
mice.
From these double stained images, we were able to quantify
numbers of cells with evidence of intracellular Aβ. The number of
MOAB2-positive neurons was signiﬁcantly higher in old APOE4
mice compared to old APOE3 mice (++P < 0.01, old APOE3 ver-
sus old APOE4, two-way ANOVAs followed by Tukey’s post hoc
analyses, Figure 2D). We did not observe any signiﬁcant differ-
ence in the numbers of MOAB2-positive neurons between young
APOE3 and young APOE4 mice (Figure 2D). When comparing
young to old mice, we observed signiﬁcantly higher numbers of
MOAB2-positive neurons in old APOE3 and old APOE4 mice
compared to their young counterparts (Figure 2D). The numbers
of MOAB2-positive neurons were signiﬁcantly less in the young
APOE3 (176 ± 10) and young APOE4 (192 ± 15) mice com-
pared to old APOE3 (233 ± 16) and old APOE4 (334 ± 22) mice
(∗P < 0.05, young APOE3 versus old APOE3; ##P < 0.01, young
APOE4 old APOE4, two-way ANOVAs followed by Tukey’s post
hoc analyses, Figure 2D). Thus, aging contributed to greater accu-
mulation of Aβ in neurons, and inheritance of APOE4 exacerbated
that effect in the old mice.
By Iba1 analyses, we did not observe any difference in the
total number of microglia depending on APOE genotype or
age (Figure 2E). However, the number of MOAB2/Iba1-positive
microglia in the old APOE4 mice was signiﬁcantly less than in
old APOE3 mice (+P < 0.05, two-way ANOVAs followed by
Tukey’s post hoc analyses, Figure 2F). We did not observe any
difference in the numbers of MOAB2/Iba1-positive microglia
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between young APOE3 and young APOE4 mice (Figure 2F).
There were fewer Aβ containing microglia in old APOE3 and old
APOE4 mice compared to young mice (Figure 2F). The num-
bers of MOAB2/Iba1-positivemicroglia in the youngAPOE3mice
(64 ± 6) and young APOE4 mice (58 ± 7) were signiﬁcantly
higher than in the old APOE3 mice (32 ± 2) and old APOE4
mice (24 ± 3; ∗∗P < 0.01, young APOE3 versus old APOE3;
##P < 0.01, youngAPOE4 oldAPOE4, two-wayANOVAs followed
by Tukey’s post hoc analyses, Figure 2F). These results suggested
that aging reduced uptake of Aβ bymicroglia and promoted intra-
neuronal accumulation of Aβ, an effect again increased in APOE4
mice.
AGING PROMOTED ACTIVATION OF CORTICAL ASTROCYTES
SURROUNDING Aβ
Although Aβ1−42 immunoreactivity was not observed in astro-
cytes (Figure 2), wemonitored the activation of cortical astrocytes
in young and aged APOE3 and APOE4 mice. Immunohisto-
chemical staining of GFAP revealed the morphological changes
of activated astrocytes associated with the aging and APOE
genotype. In the control (contralateral) cortex, GFAP positive
astrocytes were characterized by slim bodies and slender processes
extending radially from the cell body (Figure 3, ﬁrst column).
In the ipsilateral cortex around the injection site of the Aβ1−42
lentivirus (Figure 3, second column), there was increased GFAP
staining, with increased astrocyte cell body size, and dendrite
processes, signs of astrocyte activation, in all animals. Com-
pared to the young animals, activated astrocytes in the ipsilateral
cortex of both APOE3 and APOE4 aged mice exhibited intense
GFAP immunoreactivity and highly ramiﬁed morphology with
hypertrophic processes, as well as increased astrocyte numbers.
Activation of astrocytes with dense staining of the enlarged cell
bodies and the highlighted cell processes was much more promi-
nent in oldAPOE4mice. In the cortex near the lentivirus injection
center (Figure 3, third column), GFAP immunoreactive astrocytes
in young APOE3 and young APOE4 mice revealed less intense
labeling with indistinct cell bodies and cellular processes. In con-
trast, cortical astrocytes in the old APOE3 and APOE4 mice were
hypertrophic, intensely GFAP immunoreactive, with swollen cell
bodies.
AGING INCREASED TAU ACCUMULATION INDUCED BY Aβ1−42
We have previously shown that AT8-positive staining is detected
in the ipsilateral cortex of young mice (Zhao et al., 2014). Here
we observed a similar pattern of phosphorylated tau induced by
lentiviral Aβ1−42 in the ipsilateral cortex, but not contralateral
cortex, in young (2month old) and old (20–22month old)APOE3
and APOE4 brains (Figure 4). Young APOE3 mice demonstrated
FIGURE 3 | Age andAPOE genotype affect induction of astrocytic
activation by Aβ1−42. Representative DAB staining images of GFAP for
astrocytes in the contralateral cortex, ipsilateral cortex near the injection site
and injection center injection center and cortex near the injection site of
Aβ1−42 lentivirus on brain sections of young APOE3, young APOE4, old
APOE3, and old APOE4 mice 2 weeks after injection. Scale bar: 50 μm.
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slight, but clearly observable AT8-positive tau immunoreactivity
in cortical neurons near the injection site (arrows). The stain-
ing for AT8 in the young APOE4 mice was also clearly visible
in the cytoplasm of many neurons (upper panels, Figure 4).
The intracellular staining of hyperphosphorylated tau was not
evenly distributed: some regions were heavily labeled with intra-
cellular aggregate-like structures, but adjacent regions showed
little staining both in young and old mice. The older brains
also demonstrated extracellular AT8-positive tau deposits (arrow-
heads), as well as strong intracellular distributions (arrows,
Figure 4).
DISCUSSION
This lentiviral system for the controlled expression of secreted Aβ
into different tissues has allowed us to test how Aβ is metabo-
lized in the brains of old versus young mice, and whether the
metabolismwas affected byAPOE genotype. Consistent with what
we previously found (Zhao et al., 2014), APOE4 brains accumu-
lated more Aβ compared to APOE3 brains. Importantly, aging
caused a change in the accumulation of Aβ: Aβ immunoreactivity
in older brains showed more evidence of extracellular deposits,
while the younger brains showed more evidence of intracellular
Aβ. Aged brains also showed many more neurons with measure-
able Aβ compared to younger brains. These data suggest that an
aged brain is less efﬁcient at clearance of intraneuronal Aβ, and
more prone to the accumulation of extracellular Aβ.
We investigated the tissues further to test whether glial accu-
mulation of Aβ differed in aged brains, since glial clearance of
Aβ is a mechanism that may be important for preventing Aβ
accumulation in aged brains (Guenette, 2003; Mandrekar et al.,
2009; Lai and McLaurin, 2012; Thal, 2012). We found that the
brains of the younger mice had signiﬁcantly higher levels of Aβ
in microglia, evidence of better clearance through this mecha-
nism. Indeed, numbers of microglia containing Aβ were reduced
in aged brains. We did not observe Aβ in astrocytes, suggest-
ing that astrocytic clearance is less important in vivo, or that
astrocytes metabolize Aβ more efﬁciently than microglia. Since
lentiviral Aβ expression is primarily and perhaps exclusively neu-
ronal, we propose the large amount of microglial Aβ results from
the combination of efﬂux of Aβ from neurons [perhaps through
mechanisms relating to the cholesterol efﬂux molecule, ABC-A1
(Koldamova et al., 2014)], and then the subsequent uptake by
microglia.
The role of APOE in this clearance mechanism is demon-
strated in this study and our previous work (Zhao et al., 2014).
We found that the neuronal accumulation of Aβ1−42 is highest
in APOE4 mice, supporting the hypothesis that apoE is involved
in clearance of Aβ, and apoE4 is less efﬁcient at this process
(Basak et al., 2012). Our measures of Aβ in microglia suggest
that the balance of neuronal and microglial metabolism of Aβ is
altered in APOE4mice, loweringmicroglial clearance and increas-
ing intraneuronal accumulation. We hypothesize that astrocytic
apoE associates with neurons and promotes Aβ efﬂux, leading
to microglial degradation of Aβ (Jiang et al., 2008; Mandrekar-
Colucci et al., 2012), and that apoE4 is impaired in its ability to
promote this efﬂux and clearance. The complex interplay of cell-
types (astrocytic apoE aiding efﬂux of neuronal Aβ to promote
microglial clearance) emphasizes the importance of addressing
this model in vivo.
The activation of microglia can serve in a neuroprotectiveman-
ner by responding and clearing invading pathogens and local
debris (Glezer et al., 2007; Lehnardt, 2010; Rodgers and Miller,
2012). However, microglia become dysfunctional as a function
of age and display diminished capacity for normal functions
related to migration, clearance, and the ability to shift from a pro-
inﬂammatory to an anti-inﬂammatory state (Vaughan and Peters,
1974; Samorajski, 1976; Sheng et al., 1998; Ye and Johnson, 1999;
Sierra et al., 2007; Streit et al., 2009; Schuitemaker et al., 2012).
FIGURE 4 |Tau phosphorylation induced by Aβ1−42. Representative
images of DAB staining for phospho-tau pSer199/202 antibody (AT8, brown)
with Nissl staining (blue) in the contralateral or ipsilateral cortex near the
injection site of Aβ1−42 lentivirus on brain sections of young APOE3, young
APOE4, old APOE3, and old APOE4 mice 2 weeks after injection. Red arrows
indicate phosphorylated tau in neurons. Solid red arrowheads indicate
extracellular phosphorylated tau in the ipsilateral cortex of old APOE3- and old
APOE4 mice. Scale bars: 40 μm.
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This change in microglia potentially contributes to increased sus-
ceptibility and neurodegeneration as a function of age (Harry,
2013). Diminished microglial motility and reduced speed of
an acute response to injury may be the result of cell senes-
cence (Damani et al., 2011). Signaling between CX3CL1 and its
receptor CX3CR1 is critical for microglia migration in the adult
brain, and in the aged brain, levels of each are diminished
(Wynne et al., 2010; Bachstetter et al., 2011). Levels of CD200
are decreased (Frank et al., 2006) suggesting of loss of the reg-
ulatory ability of neurons to maintain microglia in a quiescent
state. Microglia isolated from aged mice compared to young
mice also showed a reduced ability in CD47-related phagocyto-
sis Aβ ﬁbrils (Floden and Combs, 2011). In APOE transgenic
mice, an age-related and genotype-related deﬁcit was observed
in the ability of the animals to mount a host-resistance response
to hippocampal injury (Harry et al., 2000). No differences were
observed between mice expressing various forms of human apoE
gene at 2 months of age, but by 8 months of age, the APOE4
mice showed a reduced ability to mount a host-response and
pro-inﬂammatory cytokine response (Harry et al., 2000). These
studies demonstrate important changes with aging that could
contribute to the reduced ability to clear Aβ, as evidenced in
our data. We propose that these changes to Aβ clearance with
aging are distinct from the processes impaired with APOE4, since
reductions were observed with aging in both APOE3 and APOE4
mice.
Astrocyte activation contributes to the failure of Aβ clearance
and the neurotoxic events downstream of Aβ in models of AD
(Garwood et al., 2011; Yan et al., 2013). As we previously found
with this system (Zhao et al., 2014), Aβ was not observed in
astrocytes. The GFAP immunoreactivity showed that astrocyte
morphology was affected by the presence of Aβ in an aging-
dependent fashion, with APOE genotype contributing to the
effects in the aged mice. Astrocytes may be responding to the
accumulation of Aβ without being involved in its clearance, or
astrocytesmaymetabolize theAβ efﬁciently and thuswe are unable
to observe its intracellular accumulation.
Intraneuronal accumulations of Aβ may be precursors to later
accumulation of amyloid plaques (Gouras et al., 2012). There may
be an important role for autophagy in degrading intraneuronal Aβ
(Burns et al., 2009; Khandelwal et al., 2011; Lonskaya et al., 2013),
and thus limiting its conversion to extracellular deposits (Nilsson
et al., 2013). Autophagic processes could be induced by several
mechanisms, but the involvement of the ubiquitin ligase complex
including Parkinmay be particularly important (Burns et al., 2009;
Khandelwal et al., 2011; Lonskaya et al., 2013). Our experiments
here demonstrate that the processes that limit the accumulation
of extracellular Aβ decay with aging, as no extracellular Aβ was
observed at 2 months or 9 months of age (Zhao et al., 2014), but
was observed after 20 months of age.
Glial activation inADbrain has been implicated in both beneﬁ-
cial and harmful processes (Keene et al., 2011; Aguzzi et al., 2013).
We did not observe large changes in microglial activation over the
2 weeks of Aβ expression, although we have consistently observed
microglial accumulation of Aβ; longer time points after lentiviral
Aβ injectionmay be needed to observe effects onmicroglial activa-
tion. Changes tomicroglia with aging have been observed (Mosher
and Wyss-Coray, 2014), and may be responsible for the changes
to the accumulation of Aβ with aging in this model. We did not
observeAβ in astrocytes in these brains, butwedidobserve a strong
change in the morphology of astrocytes in the presence of Aβ. We
believe these changes reﬂect a very early response of astrocytes to
the presence of extracellular Aβ.
Our approach has also allowed us to determine the early down-
stream effects of the presence of human Aβ on neuronal health.
We analyzed the accumulation of the AT8 phospho-tau epitope
within 2 weeks of the introduction of human Aβ. We found that
in that short time, phospho-tau was induced, and that induction
was stronger in the APOE4 mice compared to the APOE3 mice.
Furthermore, aging led to a strong induction of AT8 positivity.
These data demonstrate the power of lentiviral Aβ to recapitulate
many of the hallmarks of AD: intracellular and extracellular accu-
mulation of Aβ, microglial clearance of Aβ, astrocyte activation,
and aberrant phosphorylation of tau.
Lentiviral expression constructs are allowing new ways to
quickly study various proteins associated with neurodegenera-
tion in vivo. These proteins include Aβ42 (Burns et al., 2009;
Rebeck et al., 2010), Parkin (Algarzae et al., 2012; Hebron et al.,
2013), tau (Khandelwal et al., 2012), α-synuclein (Moussa et al.,
2008), and TDP-43 (Herman et al., 2012; Hebron et al., 2013).
Experiments with the Aβ lentivirus have demonstrated that
Parkin alters metabolism of Aβ and reduces associated neu-
rotoxic effects by promoting autophagy pathways (Burns et al.,
2009; Khandelwal et al., 2011; Algarzae et al., 2012). With
lentiviral expression, the interactions of these pathogenic pro-
teins can be quickly addressed without having to generate new
transgenic mouse models. Furthermore, this system exam-
ines the metabolism of Aβ, as opposed to other transgenic
systems that are affected by both Aβ production and clear-
ance.
Our work here shows a pathway of Aβ clearance in vivo, with
the conversion of intracellular Aβ from neurons to microglia. This
pathway is impaired in animals expressing APOE4 compared to
APOE3, and is degraded in aged animals compared to young ani-
mals. These data demonstrate that two of the strongest factors
predisposing to AD, aging and APOE4, both have effects on the
earliest stages of Aβ metabolism in vivo.
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